27334

544293

SURAKSHA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SURAKSHA DIAGNOSTIC LTD Share Price Today

SURAKSHA DIAGNOSTIC LTD is currently trading at ₹259.65, down by ₹5.89 from the previous close. The stock touched an intraday high of ₹270.00 and a low of ₹257.25 during the latest trading session. Over the past one year, SURAKSHA DIAGNOSTIC LTD has delivered a loss of 18.14%, while the stock has declined 8.17% in the last one month.

SURAKSHA DIAGNOSTIC LTD performance

Today’s low Today’s high
₹ 257.25 ₹ 270.00
₹ 264.90
52 week low 52 week high
₹ 224.10 ₹ 352.50
₹ 264.90
Open Price ₹ 265.55
Prev. Close ₹ 265.55
Volume (Shares) 34800.00
Total traded value ₹ 92.18
Upper Circuit ₹ 318.65
Lower Circuit ₹ 212.45
info

Investment Returns

Over 1 Month -8.17% Over 3 Months 4.19% Over 6 Months -5.08% Over 1 Year -18.14%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SURAKSHA DIAGNOSTIC LTD fundamentals


  • Market cap (Cr) 1,380.10
  • P/E Ratio (TTM) 40.80
  • Beta 0.55
  • Book Value / share 47.96
  • Return on equity 16.99%
  • EPS (TTM) 6.54
  • Dividend yield 0.19%
  • Net profit/quarter (Cr) 6.71
info icon alternate text
  • Market cap (Cr) 1,363.00
  • P/E Ratio (TTM) 40.80
  • Beta 0.50
  • Book Value / share 47.96
  • Return on equity 16.99%
  • EPS (TTM) 6.54
  • Dividend yield 0.19%
  • Net profit/quarter (Cr) 6.71
info icon alternate text

SURAKSHA DIAGNOSTIC LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 78.56
Operating Expense 69.31
Net Profit 6.71
Net Profit Margin (%) 8.54
Earnings Per Share (EPS) 1.29
EBITDA 25.11
Effective Tax Rate (%) 36.45
Particulars DEC 2025 (Values in Cr)
Revenue 75.58
Operating Expense 65.60
Net Profit 8.14
Net Profit Margin (%) 10.77
Earnings Per Share (EPS) 1.56
EBITDA 24.18
Effective Tax Rate (%) 25.79
Particulars SEP 2025 (Values in Cr)
Revenue 76.26
Operating Expense 64.66
Net Profit 9.36
Net Profit Margin (%) 12.27
Earnings Per Share (EPS) 1.80
EBITDA 24.94
Effective Tax Rate (%) 25.53
Particulars JUN 2025 (Values in Cr)
Revenue 70.28
Operating Expense 58.26
Net Profit 9.85
Net Profit Margin (%) 14.01
Earnings Per Share (EPS) 1.89
EBITDA 24.93
Effective Tax Rate (%) 24.92
Particulars MAR 2025 (Values in Cr)
Revenue 64.15
Operating Expense 55.04
Net Profit 8.01
Net Profit Margin (%) 12.48
Earnings Per Share (EPS) 1.54
EBITDA 20.75
Effective Tax Rate (%) 20.21
Particulars MAR 2026 (Values in Cr)
Revenue 300.68
Operating Expense 257.82
Net Profit 34.06
Net Profit Margin (%) 11.32
Earnings Per Share (EPS) 6.54
EBITDA 99.16
Effective Tax Rate (%) 27.84
Particulars MAR 2025 (Values in Cr)
Revenue 249.10
Operating Expense 209.62
Net Profit 33.44
Net Profit Margin (%) 13.42
Earnings Per Share (EPS) 6.42
EBITDA 86.97
Effective Tax Rate (%) 23.75
Particulars MAR 2024 (Values in Cr)
Revenue 218.52
Operating Expense 188.69
Net Profit 24.38
Net Profit Margin (%) 11.15
Earnings Per Share (EPS) 7.06
EBITDA 74.07
Effective Tax Rate (%) 25.43
Particulars MAR 2023 (Values in Cr)
Revenue 189.99
Operating Expense 185.69
Net Profit 7.19
Net Profit Margin (%) 3.78
Earnings Per Share (EPS) 2.08
EBITDA 48.56
Effective Tax Rate (%) 8.64
Particulars MAR 2022 (Values in Cr)
Revenue 223.19
Operating Expense 192.31
Net Profit 23.75
Net Profit Margin (%) 10.64
Earnings Per Share (EPS) 344.00
EBITDA 49.81
Effective Tax Rate (%) 28.44
Particulars MAR 2025 (Values in Cr)
Book Value / Share 40.56
ROE % 15.93
ROCE % 17.66
Total Debt to Total Equity 0.46
EBITDA Margin 34.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 257.65
ROE % 13.75
ROCE % 18.44
Total Debt to Total Equity 0.31
EBITDA Margin 33.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 223.62
ROE % 6.69
ROCE % 8.20
Total Debt to Total Equity 0.11
EBITDA Margin 15.59
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2149.92
ROE % 17.40
ROCE % 22.62
Total Debt to Total Equity 0.13
EBITDA Margin 22.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1805.72
ROE % 6.70
ROCE % 7.61
Total Debt to Total Equity 0.11
EBITDA Margin 18.67
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.15
ROE % 16.99
ROCE % 18.36
Total Debt to Total Equity 0.45
EBITDA Margin 35.18
Particulars MAR 2024 (Values in Cr)
Book Value / Share 259.76
ROE % 14.59
ROCE % 16.07
Total Debt to Total Equity 0.56
EBITDA Margin 34.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 224.63
ROE % 5.62
ROCE % 9.38
Total Debt to Total Equity 0.38
EBITDA Margin 27.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2150.51
ROE % 17.40
ROCE % 22.61
Total Debt to Total Equity 0.13
EBITDA Margin 22.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1806.30
ROE % 6.72
ROCE % 7.64
Total Debt to Total Equity 0.11
EBITDA Margin 18.70
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 20.10
Total Assets 333.52
Total Liabilities 333.52
Total Equity 210.23
Share Outstanding 5
Price to Book Ratio 6.26
Return on Assets (%) 9.54
Return on Capital (%) 14.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 55.02
Total Assets 300.20
Total Liabilities 300.20
Total Equity 179.14
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.86
Return on Capital (%) 12.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.03
Total Assets 281.19
Total Liabilities 281.19
Total Equity 155.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.31
Return on Capital (%) 3.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.82
Total Assets 200.71
Total Liabilities 200.71
Total Equity 149.97
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 11.83
Return on Capital (%) 14.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.43
Total Assets 171.04
Total Liabilities 171.04
Total Equity 126.22
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.76
Return on Capital (%) 4.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 15.52
Total Assets 333.10
Total Liabilities 333.10
Total Equity 214.31
Share Outstanding 5
Price to Book Ratio 6.26
Return on Assets (%) 10.03
Return on Capital (%) 15.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 52.80
Total Assets 301.74
Total Liabilities 301.74
Total Equity 180.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.08
Return on Capital (%) 12.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 54.62
Total Assets 282.05
Total Liabilities 282.05
Total Equity 156.62
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.54
Return on Capital (%) 4.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 45.13
Total Assets 283.87
Total Liabilities 283.87
Total Equity 149.42
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.36
Return on Capital (%) 14.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.35
Total Assets 171.07
Total Liabilities 171.07
Total Equity 126.26
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.78
Return on Capital (%) 4.54
Particulars MAR 2025 (Values in Cr)
Net Income 41.40
Cash from Operations 73.94
Cash from Investing -39.58
Cash from Financing -24.04
Net change in Cash -0.27
Free Cash Flow 115.96
Particulars MAR 2024 (Values in Cr)
Net Income 31.45
Cash from Operations 69.09
Cash from Investing -34.99
Cash from Financing -25.12
Net change in Cash 0.35
Free Cash Flow 114.56
Particulars MAR 2023 (Values in Cr)
Net Income 6.74
Cash from Operations 51.29
Cash from Investing -20.79
Cash from Financing -24.32
Net change in Cash -1.02
Free Cash Flow 64.45
Particulars MAR 2022 (Values in Cr)
Net Income 33.19
Cash from Operations 46.77
Cash from Investing -43.78
Cash from Financing 1.08
Net change in Cash -0.35
Free Cash Flow 66.02
Particulars MAR 2021 (Values in Cr)
Net Income 6.37
Cash from Operations 25.61
Cash from Investing -27.70
Cash from Financing 3.21
Net change in Cash -0.98
Free Cash Flow 41.01
Particulars MAR 2025 (Values in Cr)
Net Income 43.85
Cash from Operations 73.37
Cash from Investing -39.28
Cash from Financing -24.14
Net change in Cash -0.63
Free Cash Flow 108.76
Particulars MAR 2024 (Values in Cr)
Net Income 32.70
Cash from Operations 69.82
Cash from Investing -35.03
Cash from Financing -25.83
Net change in Cash 0.36
Free Cash Flow 112.04
Particulars MAR 2023 (Values in Cr)
Net Income 7.87
Cash from Operations 52.11
Cash from Investing -22.04
Cash from Financing -24.32
Net change in Cash -1.44
Free Cash Flow 65.22
Particulars MAR 2022 (Values in Cr)
Net Income 33.19
Cash from Operations 46.76
Cash from Investing -43.69
Cash from Financing 1.08
Net change in Cash -0.27
Free Cash Flow 65.87
Particulars MAR 2021 (Values in Cr)
Net Income 6.41
Cash from Operations 25.64
Cash from Investing -27.71
Cash from Financing 3.21
Net change in Cash -0.96
Free Cash Flow 44.40
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.45 62.45 12.89 122165.91 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 77.00
SHREE PACETRONIX LTD. 137.90 16.46 2.90 51.71 66.10 283.15
TRANSGENE BIOTEK LTD. 2.94 0.00 2.65 22.28 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.45 81.38 12.26 122165.91 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.94 0.00 -9.47 29.09 30.30 57.48
KOVAI MEDICAL CENTER & HO 5803.05 25.97 4.81 6348.54 5010.00 6725.00

SURAKSHA DIAGNOSTIC LTD shareholding pattern

Holding
14.3%
49.09%
13.45%
23.13%
0.1%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SURAKSHA DIAGNOSTIC LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
265.00 -0.20 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 268.60
  • 26 Days 280.20
  • 10 Days 272.50
  • 50 Days 280.80
  • 12 Days 274.10
  • 100 Days 280.50
  • 20 Days 278.60
  • 200 Days 286.70
269.85 PIVOT
First Support 263.75 First Resistance 274.15 Second Support 259.45 Second Resistance 280.25 Third Support 253.35 Third Resistance 284.55
RSI 37.61 ADX 16.71 MACD -5.20 Williams % R -88.99 Commodity Channel Index (CCI) -121.01
Date 2026-06-12 Week 19894.00 Same Day 14048.00 Month 28393.00
1 Year 0.56 3 Year 0.74
Over 1 Month
-8.17% down
Over 1 Year
-18.14% down
Over 3 Months
4.19% down
Over 3 Years
0.00% down
Over 6 Months
-5.08% down
Over 5 Years
0.00% down

SURAKSHA DIAGNOSTIC LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Suraksha Diagnostic Ltd?

Answer Field

Suraksha Diagnostic Ltd share price is for NSE ₹ 259.65 & for BSE ₹ 261.70 as on Jun 18 2026 03:30 PM.

What is the Market Cap of Suraksha Diagnostic Ltd Share?

Answer Field

The market cap of Suraksha Diagnostic Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 03:30 PM.

What is the 52 Week High and Low of Suraksha Diagnostic Ltd?

Answer Field

The 52 Week High and Low of Suraksha Diagnostic Ltd for NSE is ₹ 352.50 and ₹ 224.10 and for BSE is ₹ 353.65 and ₹ 224.10.

What is 1 year return for Suraksha Diagnostic Ltd?

Answer Field

The 1 year returns on the stock has been -17.82%.

What is the P/E Ratio of Suraksha Diagnostic Ltd Share?

Answer Field

As on Jun 18 2026 03:30 PM the price-to-earnings (PE) ratio for Suraksha Diagnostic Ltd share is 40.80.

What is the PB ratio of Suraksha Diagnostic Ltd Share?

Answer Field

As on Jun 18 2026 03:30 PM, the price-to-book (PB) ratio for Suraksha Diagnostic Ltd share is 47.96.

How to Buy Suraksha Diagnostic Ltd Share?

Answer Field

You can trade in Suraksha Diagnostic Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Suraksha Diagnostic Ltd Share on Bajaj Broking App?

Answer Field

To buy Suraksha Diagnostic Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Suraksha Diagnostic Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|